Maryland’s one-of-a-kind system for regulating hospital costs protected health care facilities from financial ruin during the pandemic. Meanwhile, it saved money and improved quality of care, according to a recent report.
Those living in Baltimore and surrounding regions are at high risk for Lyme disease transmission through tick bites. An expert from Johns Hopkins’ Lyme research center explains why and shares ways to avoid tick-borne illness.
Persistent stigma and misunderstanding of ADHD may be contributing to an apparent lack of political will to resolve the shortage of medications to treat it.
Baltimore County Detective Jonathan Chih sustained critical injuries when police say he was shot by David Emory Linthicum on Feb. 9, on the second day of manhunt for the gunman.
Physician-scientists at University of Maryland School of Medicine are testing radically different ways to stem the catastrophic blood loss that often kills trauma victims — one using a Tang-like, artificial blood powder and another by inducing hypothermia.
Governor Wes Moore and U.S. Secretary of Health and Human Services Xavier Becerra highlight federal and state investments in youth mental health at roundtable event in Baltimore.
Lawsuit accuses the Maryland Department of Human Services and its Social Services Administration of overusing psychotropic medications as a form of “chemical restraint” for some kids with severe behavioral health problems.
The FDA changed its rules to allow the abortion pill to be obtained at the pharmacy counter instead of in-person from a provider. It’s up to pharmacies whether they will comply.
Insulin copays dropped to $30 maximum per month for privately insured Marylanders and $35 for those with Medicare January 1, thanks to new state and federal laws.
What’s next for Maryland’s first-of-its-kind Prescription Drug Price Affordability Board, and will its innovative approach to lowering drug prices succeed?